These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Statin-naïve anti-HMGCR antibody-mediated necrotizing myopathy in China. Jiao Y, Cai S, Lin J, Zhu W, Xi J, Li J, Yue D, Zhang T, Qiao K, Wang Y, Zhao C, Lu J. J Clin Neurosci; 2018 Nov; 57():13-19. PubMed ID: 30205933 [Abstract] [Full Text] [Related]
26. Statins and myotoxic effects associated with anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase autoantibodies: an observational study in Japan. Watanabe Y, Suzuki S, Nishimura H, Murata KY, Kurashige T, Ikawa M, Asahi M, Konishi H, Mitsuma S, Kawabata S, Suzuki N, Nishino I. Medicine (Baltimore); 2015 Jan; 94(4):e416. PubMed ID: 25634171 [Abstract] [Full Text] [Related]
27. Necrotizing Autoimmune myopathy: A case report on statin induced rhabdomyolysis requiring immunosuppressive therapy. Kunwar S, Parekh JD, Chilukuri RS, Andukuri VA. Drug Discov Ther; 2018 Jan; 12(5):315-317. PubMed ID: 30464165 [Abstract] [Full Text] [Related]
36. Statins and myositis: the role of anti-HMGCR antibodies. Selva-O'Callaghan A, Alvarado-Cardenas M, Marin A, Pinal-Fernandez I. Expert Rev Clin Immunol; 2015 Apr; 11(12):1277-9. PubMed ID: 26492593 [Abstract] [Full Text] [Related]
37. Paraneoplastic Anti-3-hydroxy-3-methylglutary-coenzyme A Reductase Antibody-positive Immune-mediated Necrotizing Myopathy in a Patient with Uterine Cancer. Mizuma A, Kouchi M, Netsu S, Yutani S, Kitao R, Suzuki S, Murata K, Nagata E, Takizawa S. Intern Med; 2017 Apr; 56(14):1915-1918. PubMed ID: 28717093 [Abstract] [Full Text] [Related]